Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older

X-Linked Agammaglobulinemia

COVID-19 Vaccine Responses in PIDD Subjects Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.